Surrey Hospitals Foundation has invested in two innovative technologies to kick-start a new minimally invasive Interventional Oncology Program at Surrey Memorial Hospital (SMH), a first in our community.
Together with several donors including McQuarrie LLP, Peak Products Manufacturing, the Athwal family, and a generous anonymous donor, we have funded a Microwave Ablation Machine and a Cryoablation Machine for the Interventional Radiology team. Both ablation machines enable Interventional Radiologists to treat various types of cancerous tumours and other lesions in a minimally invasive manner using tiny needles and small incisions. This reduces the need for general anesthesia and results in faster recovery times for patients compared to traditional surgery, with most patients being discharged from the hospital a few hours after the procedure.
Interventional Radiology is a revolutionary medical specialty, dubbed “surgery without a scalpel”, that utilizes minimally invasive image-guided techniques to diagnose and treat complex conditions including cancer, diseases of the vascular system, as well as multitude of conditions affecting men and women’s health. Led by Dr. Behrang Homayoon, the Interventional Radiology team at SMH consists of highly trained interventional radiologists, specialty trained nurses and x-ray technologists, who are dedicated to providing quality care.
“There is an ever increasing need for minimally invasive cancer treatments, and Canada needs to catch up to other G7 countries in providing widespread access to these advanced therapies, which is why I am excited to launch this new IR program and expand our dedicated team of specialists here at SMH to address this need” says Dr. Homayoon, lead interventional radiologist at SMH. “I am grateful to the Surrey Hospitals Foundation for their investment in these ablation machines, which will be a huge benefit to Fraser Valley residents.”
“Surrey and the Fraser Valley encompass a huge region and we have a major cancer treatment centre at SMH, so we are fortunate to recruit a team of specialists like Dr. Homayoon, Dr. Lourenco and Dr. Strovski to Surrey to start this critical program,” says Jane Adams, President & CEO of the Surrey Hospitals Foundation. “It is absolutely crucial that we invest in innovative technologies to support the IR program at SMH so they can provide enhanced medical care, especially to those with cancer, closer to home.”
Together, we are providing unstoppable, life-changing health care to residents in Surrey.